钆对比剂在海马蓄积及对神经元线粒体的影响
该研究通过小鼠实验自身免疫性脑脊髓炎模型与器官型海马切片培养,评估线性钆喷酸葡胺与环状钆布醇暴露后的海马钆蓄积及线粒体效应。结果显示海马长期钆蓄积仅见于线性钆对比剂,而体外实验中两类对比剂在生物相关浓度下均可改变神经元线粒体形态与动力学,炎症可放大该效应。
要点
- 海马长期钆蓄积在体内仅与线性钆对比剂相关,尤其在有神经炎症时更明显
- 体外低到中等浓度下,线性与环状钆对比剂均可改变神经元线粒体长度、面积与运动性
- 炎症条件下线粒体损伤更显著,神经炎性疾病患者使用钆对比剂需关注潜在神经毒性风险
核心结论
- 体内海马长期钆蓄积似乎仅限于线性钆对比剂,而体外生物相关浓度下线性与环状钆对比剂均可改变神经元线粒体形态与动力学
- 炎症条件可进一步放大钆对比剂相关线粒体效应,在评估潜在神经毒性风险时需特别考虑神经炎性疾病背景
研究设计与样本
- 动物体内研究采用实验性自身免疫性脑脊髓炎小鼠与健康对照,重复注射线性钆喷酸葡胺或环状钆布醇,累计剂量为20 mmol/kg体重
- 体内研究于末次注射后1、10、40天利用激光剥蚀电感耦合等离子体飞行时间质谱分析海马钆分布与滞留动力学
- 体外研究采用表达荧光标记神经元线粒体的小鼠器官型海马切片培养,给予TNF-α模拟炎症并暴露于0.1、1、10、50 mM钆喷酸葡胺或钆布醇48小时
- 体外线粒体动力学通过共聚焦显微镜半自动与人工分析定量,切片钆含量采用电感耦合等离子体质谱测定
关键影像表现/征象
- 体内实验中神经炎症增加实验性自身免疫性脑脊髓炎小鼠海马对两类钆对比剂的摄取蓄积
- 末次注射后40天长期海马钆滞留仅见于钆喷酸葡胺组,且在实验性自身免疫性脑脊髓炎小鼠中尤为突出
- 体外0.1至10 mM浓度下两类钆对比剂均使神经元线粒体长度和面积减小,并相对未处理对照改变线粒体运动性
- 明显运动性障碍与线粒体变圆仅出现于最高钆喷酸葡胺浓度(50 mM)条件下
诊断标准与关键数值
- 体外0.1至10 mM为研究关注的低至中等浓度范围,该浓度下组织内钆水平处于生物相关且亚细胞毒性范围
- 炎症未改变体外切片内钆浓度,但炎症条件下线粒体形态与动力学改变更为明显
临床应用与阅片要点
- 放射科与超声科医生在神经炎性疾病患者中使用钆对比剂时,应优先考虑环状钆对比剂以减少长期脑内钆滞留风险
- 即使环状钆对比剂体内长期蓄积较少,体外数据提示其在生物相关浓度下仍可能影响神经元线粒体,阅片相关风险评估不应只依赖体内蓄积数据
- 解读含钆对比剂增强影像时需结合患者炎症状态,炎症可能放大钆相关神经毒性效应
局限性
- 研究基于动物模型与体外器官型切片培养,向人体的外推存在不确定性
- 体外暴露浓度范围较宽,0.1至10 mM与人常规给药后脑内实际浓度对应关系未明确
- 结论中体内长期滞留仅支持线性钆对比剂,体外转归与体内浓度之间缺乏直接映射
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: In multiple sclerosis (MS), mitochondrial dysfunction contributes to disease progression and may impair cognitive function, particularly in vulnerable regions such as the hippocampus. Gadolinium-based contrast agents (GBCAs) are widely used for imaging-based diagnosis of MS; however, evidence indicates that gadolinium (Gd) can be released from low-stability agents and retained in the brain. Whether retained Gd affects neuronal mitochondria, particularly under inflammatory conditions, remains unclear. We investigated hippocampal Gd retention following in vivo GBCA exposure and assessed associated mitochondrial effects in hippocampal slice cultures.
METHODS: Mice with experimental autoimmune encephalomyelitis (EAE) and healthy controls received repeated injections of linear gadopentetate-dimeglumine (gadopentetate) or macrocyclic gadobutrol (cumulative dose: 20 mmol/kg body weight). Hippocampal Gd distribution and retention kinetics were analyzed 1, 10, and 40 days post-final injection (p.f.i.) using laser ablation inductively coupled plasma-time-of-flight mass spectrometry (LA-ICP-ToF-MS). Ex vivo, organotypic hippocampal slice cultures from B6.Cg-Tg(Thy1-CFP/COX8A)S2Lich/J mice expressing fluorescently labeled neuronal mitochondria were exposed to TNF-alpha (paradigm of inflammation)±gadopentetate or gadobutrol for 48 hours (0.1, 1, 10, 50 mM). Mitochondrial dynamics were quantified using semi-automated and manual analyses of confocal microscopy images, and Gd slice content was determined by ICP-MS.
RESULTS: In vivo, neuroinflammation increased hippocampal Gd accumulation following administration of both GBCAs in EAE mice. However, long-term retention up to 40 days p.f.i. was observed exclusively for gadopentetate, particularly in EAE mice. Ex vivo, prolonged exposure to both GBCAs at low-to-intermediate concentrations (0.1 to 10 mM) reduced mitochondrial length and area, particularly under inflammatory conditions, and altered mitochondrial motility relative to untreated controls. At these concentrations, intratissue Gd levels, quantified by ICP-MS under representative conditions, were within a biologically relevant, sub-cytotoxic range. Marked motility impairment and mitochondrial rounding occurred only at the highest gadopentetate concentration (50 mM). Interestingly, although inflammation did not alter Gd concentrations within the ex vivo slices, mitochondrial alterations were more pronounced under inflammatory conditions.
CONCLUSION: In the hippocampus, long-term Gd retention in vivo appears to be restricted to linear GBCAs, whereas ex vivo, exposure to both linear and macrocyclic GBCAs at biologically relevant concentrations alters neuronal mitochondrial morphology and dynamics. Inflammation further amplifies these effects, highlighting the importance of considering GBCA-associated mitochondrial damage when evaluating their potential neurotoxic risks, particularly in neuroinflammatory diseases.
引用
- Ludwig, Schannor, Traub, et al. Gadolinium-based Contrast Agents Trigger Gadolinium Accumulation Within the Hippocampus In Vivo and Mitochondrial Alterations in Organotypic Hippocampal Tissue Cultures Ex Vivo. Invest Radiol. 2026. PMID: 42764798. doi:10.1097/RLI.0000000000001315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。